Under the collaboration, Emerson’s DeltaV distributed control system will be integrated with GE’s technologies to manufacture monoclonal antibodies, vaccines and other biologics.
The initial DeltaV-driven GE Healthcare installation will be a FlexFactory, GE’s manufacturing platform based on single-use technologies.
Manufacturers are reducing set-up times and increasing production flexibility with the help of GE’s start-to-finish portfolio of single-use bioprocessing technologies.
Emerson’s DeltaV system allows remote monitoring and control from various locations across a company’s network.
The DeltaV system will be offered as an automation control platform for GE’s single-use bioprocessing techniques.
The collaboration will help drive improvements in productivity and bring benefits to global healthcare providers.
Emerson Process Management senior vice president of industry solutions Jerry Brown said: "We believe that the combination of Emerson’s automation technologies and the GE FlexFactory will offer superior process performance, consistency of product, and reduced validation time.
"This collaboration will support more predictable processes that eliminate unnecessary work, which translates into a reduced time to market for our customers."